LEASES

12 Months Ended

Sep. 30, 2025

Leases [Abstract]

LEASES

10. LEASES

The Company leases office and research and development facilities under non-cancelable operating leases for various terms through 2031. Certain lease agreements include renewal options, rent abatement periods, and rental increases throughout the term. Operating lease costs are included within cost of revenue, selling and marketing, research and development, and general and administrative expenses, dependent upon the nature and use of the ROU asset, in the Company’s consolidated statements of operations and comprehensive income (loss).

The following table provides the components of lease cost recognized in the consolidated statements of operations and comprehensive income (loss) for the periods presented (amounts in thousands):

	Twelve Months Ended September 30,
	2025		2024		2023
Operating lease costs	$	747	$	1,784	$	2,025
Short-term lease costs	528		384		150
Variable lease costs	203		249		169
Total lease costs	$	1,478	$	2,417	$	2,344

Supplemental cash flow information related to leases was as follows (amounts in thousands):

	Twelve Months Ended September 30,
	2025		2024		2023
Right of use assets acquired under new operating leases	$	429	$	1,947	$	—
Cash paid for amounts included in the measurement of lease liabilities	845		1,960		2,368

Other information related to leases as of the balance sheet dates presented was as follows:

	Twelve Months Ended September 30,
	2025		2024
Weighted-average remaining lease term (years) - operating leases	4.0		5.3
Weighted-average discount rate - operating leases	7.8	%	3.6	%

Maturities of operating lease liabilities as of September 30, 2025 were as follows (amounts in thousands):

	Operating Leases
2026	$	1,081
2027	990
2028	479
2029	314
2030	323
Thereafter	286
Total lease payments	$	3,473
Less: amount representing interest	(503)
Present value of future lease payments	$	2,970